Heparan sulfate acetyl-CoA:␣-glucosaminide N-acetyltransferase (HGSNAT) catalyzes the transmembrane acetylation of heparan sulfate in lysosomes required for its further catabolism. Inherited deficiency of HGSNAT in humans results in lysosomal storage of heparan sulfate and causes the severe neurodegenerative disease, mucopolysaccharidosis IIIC (MPS IIIC). Previously we have cloned the HGSNAT gene, identified molecular defects in MPS IIIC patients, and found that all missense mutations prevented normal folding and trafficking of the enzyme. Therefore characterization of HGSNAT biogenesis and intracellular trafficking became of central importance for understanding the molecular mechanism underlying the disease and developing future therapies.In the current study we show that HGSNAT is synthesized as a catalytically inactive 77-kDa precursor that is transported to the lysosomes via an adaptor protein-mediated pathway that involves conserved tyrosine-and dileucine-based lysosomal targeting signals in its C-terminal cytoplasmic domain with a contribution from a dileucine-based signal in the N-terminal cytoplasmic loop. In the lysosome, the precursor is cleaved into a 29-kDa N-terminal ␣-chain and a 48-kDa C-terminal -chain, and assembled into active ϳ440-kDa oligomers. The subunits are held together by disulfide bonds between at least two cysteine residues (Cys 123 and Cys 434 ) in the lysosomal luminal loops of the enzyme. We speculate that proteolytic cleavage allows the nucleophile residue, His 269 , in the active site to access the substrate acetyl-CoA in the cytoplasm, for further transfer of the acetyl group to the terminal glucosamine on heparan sulfate. Altogether our results identify intralysosomal oligomerization and proteolytic cleavage as two steps crucial for functional activation of HGSNAT.
Integral lysosomal membrane proteins (LMP)3 are crucial components of the lysosomal membrane where they play a structural role, maintain the pH of the lysosomal lumen, and are responsible for transport of macromolecules into and degradation products out of the lysosome. Proper functioning of LMP is therefore essential to maintain cellular homeostasis. Defects in genes encoding LMP cause a number of severe inherited human disorders involving lysosomes and lysosome-related organelles, such as melanosomes, lytic granules, major histocompatibility complex (MHC) class II compartments, and platelet dense granules as primary targets (reviewed in Refs. 1-3). Within the last decade the number of known LMP and disorders caused by their deficiencies extended from just a few to 27 and the new LMP are continuing to be revealed (4). In most cases, however, cloning the genes encoding LMP and identification of causative mutations did not result in immediate understanding of biochemical mechanisms of the corresponding disorders due to a lack of structure-function information in identified LMP.The above proved true, in particular, for heparan sulfate acetyl-CoA:␣-glucosaminide N-acetyltransferase (HGSNAT, EC 2.3.1.78) recently cloned...